3D organoids | Regenerative Medicine Innovation Platform | Precision medicine platform
Fuyou Life is a high-tech enterprise specializing in precise drug sensitivity screening for organoids and tumors. By 2025, the company will establish a key academician workstation in Jinan, and, relying on academician research resources, will lead the formation of the Yangtze River Delta (G35) Organoid Industry Innovation Alliance, collaborating with multiple research institutes to build laboratories and break through core organoid technologies. The company's self-developed integrated testing solutions and multi-cancer drug susceptibility databases provide precise support for personalized tumor medication, improving patient treatment and quality of life.
Explore more
Breaking through traditional treatment bottlenecks, iPSC-induced cardiomyocyte agents are a new technology for treating heart failure, myocardial infarction, and other diseases.
See details
Respiratory disease treatment is based on organoid platform assessment services and model products.
Explore technology
Fuyouyou Life | Skin organoids, protecting skin health, precise prevention, repair, and adjunctive treatment.
Learn more
2026.06.02
See details